BioCentury
ARTICLE | Company News

Daiichi Sankyo, Ranbaxy infectious, inflammation news

July 5, 2010 7:00 AM UTC

Daiichi will incorporate the New Drug Discovery Research (NDDR) program of Ranbaxy into its Daiichi Sankyo India Pharma Private Ltd. R&D unit. The program will be renamed the Daiichi Sankyo Life Scien...